US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TRIBECA STRATEGIC ACQUISITION CORP

9.91

-0.0300-0.30%

Volume:2K

Turnover:15.93K

Market Cap:191.03M

PE:-139.25

High:9.93

Open:9.92

Low:9.91

Close:9.94

52wk High:10.02

52wk Low:9.83

Shares:19.28M

Float Shares:12.97M

Volume Ratio:1.45

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0712

EPS(LYR):-0.0712

ROE:--

ROA:--

PB:-2615.87

PE(LYR):-139.25

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Press Release: Aurora Cannabis Corrects Inaccurate Statements MADE in Support of Curaleaf Holdings' Hostile BID

Press Release: Terravest Announces Renewal of Normal Course Issuer BID for ITS Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BID"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BID","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BID\",,,,,undefined,":{"symbol":"BID","market":"US","secType":"STK","nameCN":"TRIBECA STRATEGIC ACQUISITION CORP","latestPrice":9.91,"timestamp":1789416000000,"preClose":9.94,"halted":0,"volume":1606,"delay":0,"changeRate":-0.0030181086519114044,"floatShares":12973000,"shares":19276700,"eps":-0.071166,"marketStatus":"Pre-Mkt","change":-0.03,"latestTime":"09-15 04:26:09 EDT","open":9.92,"high":9.93,"low":9.91,"amount":15931,"amplitude":0.002012,"askPrice":15.91,"askSize":100,"bidPrice":8.98,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.071166,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1784520000000,"exchange":"NASDAQ","adjPreClose":9.91,"volumeRatio":1.447107599991959},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BID\",,,,,undefined,":{"symbol":"BID","floatShares":12973000,"roa":"--","roe":"--","lyrEps":-0.071166,"volumeRatio":1.447107599991959,"shares":19276700,"dividePrice":0,"high":9.93,"amplitude":0.002012,"preClose":9.94,"low":9.91,"week52Low":9.825,"pbRate":"-2615.87","week52High":10.015,"institutionHeld":0.9362,"latestPrice":9.91,"eps":-0.071166,"divideRate":0,"volume":1606,"delay":0,"ttmEps":-0.071166,"open":9.92,"prevYearClose":9.9,"prevWeekClose":9.94,"prevMonthClose":9.89,"prevQuarterClose":9.9,"fiveDayClose":10.01,"twentyDayClose":9.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BID\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BID\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BID\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BID\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BID","date":"2026-09-11","current":-139.25189,"percent":0.108108,"low":-581.007118,"twenty":-574.622426,"median":-572.300718,"eighty":-571.139865,"high":-570.559438,"avg":-573.2835,"sd":2.658543,"marketCap":191610069},"quantilePoints":[{"date":"2026-07-24","current":-570.617481,"twenty":-572.387997,"median":-571.139865,"eighty":-570.605872,"marketCap":189508913},{"date":"2026-07-31","current":-571.139865,"twenty":-571.372035,"median":-571.139865,"eighty":-570.559438,"marketCap":189682403},{"date":"2026-08-07","current":-571.72029,"twenty":-571.72029,"median":-571.139865,"eighty":-570.594264,"marketCap":189875169},{"date":"2026-08-14","current":-574.622426,"twenty":-571.952461,"median":-571.139865,"eighty":-570.756782,"marketCap":190839003},{"date":"2026-08-21","current":-572.300718,"twenty":-572.300718,"median":-571.72029,"eighty":-571.023779,"marketCap":190067936},{"date":"2026-08-28","current":-574.622426,"twenty":-573.113316,"median":-571.72029,"eighty":-571.139865,"marketCap":190839003},{"date":"2026-09-04","current":-578.68541,"twenty":-574.041998,"median":-572.300718,"eighty":-571.139865,"marketCap":192188369},{"date":"2026-09-11","current":-576.94413,"twenty":-574.622426,"median":-572.300718,"eighty":-571.139865,"marketCap":191610069}],"updateTime":1789460769804},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BID\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667769623","title":"Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667769623","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667769623?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:01","pubTimestamp":1789416060,"startTime":"0","endTime":"0","summary":"Post hoc analyses of SION-719 PreciSION CF subset showed a mean placebo-adjusted sweat chloride reduction of up to -8.6 mmol/L consistent with NBD1 biological activity Dual combination Phase 2a trial ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3361527/0/en/sionna-therapeutics-announces-plans-to-advance-sion-451-sion-2222-dual-combination-into-phase-2a-proof-of-concept-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BID","LU0345780950.USD","LU0345781412.USD","VEGI","BK4093","CF","KBWY","BK4588","SION","BK4139","BK4585","PK","LU0630314457.HKD","BK4181","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715769","title":"Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715769","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715769?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:30","pubTimestamp":1787743800,"startTime":"0","endTime":"0","summary":"Professor Marlies Wijsenbeek will give an oral presentation on the quality-of-life outcomes assessed by the LCQ from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-re","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351240/0/en/trevi-therapeutics-announces-upcoming-presentations-at-the-european-respiratory-society-ers-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","FAS","BID","RCC","EPV","BK4539","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661914273","title":"Press Release: Aurora Cannabis Corrects Inaccurate Statements MADE in Support of Curaleaf Holdings' Hostile BID","url":"https://stock-news.laohu8.com/highlight/detail?id=2661914273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661914273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:05","pubTimestamp":1787569500,"startTime":"0","endTime":"0","summary":"-- Curaleaf's self-serving portrayal of our business is an attempt to. acquire Aurora's world class EU-GMP manufacturing facilities and global. medical cannabis footprint at the lowest price possible. -- Aurora's international strategy is working; net revenue is up 17%YOY. -- Contrary to Curaleaf's inaccurate statements, Aurora's high margin German. business is growing and continues to be a key driver of Aurora's. -- Shareholders are advised to TAKE NO ACTION pending formal recommendation. from the Board and Special Committee. Offer remains open for at least 105. -- Questions about the Offer or would like to stay informed?Kingsdale Advisors toll-free at 1-800-749-9052 within North America, call","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","YOLO","BK4588","CURLF","WEED","ACB","MJ","TM","BK4557","MSOX","BK4099","BK4555","R","03160","BK4585","BK4232","MSOS","TOKE","BK4022","BID","BK4007","CNBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660475362","title":"Press Release: Terravest Announces Renewal of Normal Course Issuer BID for ITS Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475362","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475362?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:00","pubTimestamp":1787173200,"startTime":"0","endTime":"0","summary":"VEGREVILLE, AB, Aug. 19, 2026 /CNW/ -- TerraVest Industries Inc. (\"TerraVest\" or the \"Corporation\") (TSX: TVK) announced today that it has received the approval of the Toronto Stock Exchange (the \"TSX","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BID"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BID\",params:#limit:6,delay:false,,,undefined,":[]}}